Back
Alphatec Holdings Vs. Perspective Therapeutics Industry Stock Comparison
Sell
42
ATEC
Alphatec Holdings
Last Price:
5.57
Seasonality Move:
3.49%
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.54
Seasonality Move:
-10.27%
Sell
42
Alphatec Holdings (ATEC)
is a Sell
Is Alphatec Holdings a Buy, Sell or Hold?
- The current Alphatec Holdings [ATEC] share price is $5.56. The Score for ATEC is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ATEC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $12.57. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATEC Stock Price Chart
What is Alphatec Holdings's stock price today?
-
The Alphatec Holdings share price today is $5.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATEC is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $12.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
ATEC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 37.28 | Sell |
| Chaikin Money Flow: | -1137907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.54 - 6.5) | Sell |
| Bollinger Bands (100): | (6.46 - 11.08) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 39.77 | Sell |
| Chaikin Money Flow: | -64266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.01 - 15.73) | Sell |
| Bollinger Bands (100): | (11.41 - 15.47) | Sell |
ATEC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.77 | Sell |
| 20-day SMA: | 5.96 | Sell |
| 50-day SMA: | 6.9 | Sell |
| 200-day SMA: | 11.56 | Sell |
| 8-day EMA: | 5.67 | Sell |
| 20-day EMA: | 5.93 | Sell |
| 50-day EMA: | 6.94 | Sell |
| 200-day EMA: | 10.25 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.69 | Sell |
| 20-day SMA: | 14.08 | Sell |
| 50-day SMA: | 13.75 | Sell |
| 200-day SMA: | 11.57 | Buy |
| 8-day EMA: | 12.79 | Sell |
| 20-day EMA: | 13.53 | Sell |
| 50-day EMA: | 13.63 | Sell |
| 200-day EMA: | 11.56 | Buy |
Alphatec Holdings Earnings Growth & ATEC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.01 per share, and an increase next year of $0.23 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Alphatec Holdings Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||